CD274 and non-small cell lung carcinoma: In the present study, we established a prediction model based on PET/CT images and clinicopathological characteristics to predict the expression of PD-L1 in NSCLC patients and provided a novel strategy for clinicians to screen the patients who could benefit from anti-PD-L1 immunotherapy.